The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Krabbe Disease Drugs Market Research Report 2025

Global Krabbe Disease Drugs Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1713822

No of Pages : 86

Synopsis

Market Analysis and Insights: Global Krabbe Disease Drugs Market

Krabbe disease is an uncommon and typically deadly concern of the nervous system. It is an acquired hereditary sickness, which implies that it is passed down in families. Individuals with Krabbe disease are not able to make a sufficient substance called galactosylceramidase, which is expected to make myelin in a human body.

The global Krabbe Disease Drugs market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Globally North America is the largest market for Krabbe disease treatment. Europe is the second-largest market and Asia Pacific is expected to grow at a fastest rate.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Krabbe Disease Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Krabbe Disease Drugs market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Krabbe Disease Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Krabbe Disease Drugs market.

Global Krabbe Disease Drugs Scope and Market Size
Krabbe Disease Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Krabbe Disease Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Anticonvulsants
  • Muscle Relaxants
  • Others

Segment by Application

  • Hospitals
  • Clinics
  • Research Centers
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

By Company

  • Glaxosmithkline
  • Johnson & Johnson
  • Novartis
  • Pfizer
  • Sanofi
  • Abbott Laboratories
  • Teva Pharmaceutical
  • Takeda
  • Ucb Pharmaceuticals
Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Krabbe Disease Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Anticonvulsants
1.2.3 Muscle Relaxants
1.2.4 Others
1.3 Market by Application
1.3.1 Global Krabbe Disease Drugs Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Krabbe Disease Drugs Market Perspective (2017-2028)
2.2 Krabbe Disease Drugs Growth Trends by Region
2.2.1 Krabbe Disease Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Krabbe Disease Drugs Historic Market Size by Region (2017-2022)
2.2.3 Krabbe Disease Drugs Forecasted Market Size by Region (2023-2028)
2.3 Krabbe Disease Drugs Market Dynamics
2.3.1 Krabbe Disease Drugs Industry Trends
2.3.2 Krabbe Disease Drugs Market Drivers
2.3.3 Krabbe Disease Drugs Market Challenges
2.3.4 Krabbe Disease Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Krabbe Disease Drugs Players by Revenue
3.1.1 Global Top Krabbe Disease Drugs Players by Revenue (2017-2022)
3.1.2 Global Krabbe Disease Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Krabbe Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Krabbe Disease Drugs Revenue
3.4 Global Krabbe Disease Drugs Market Concentration Ratio
3.4.1 Global Krabbe Disease Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Krabbe Disease Drugs Revenue in 2021
3.5 Krabbe Disease Drugs Key Players Head office and Area Served
3.6 Key Players Krabbe Disease Drugs Product Solution and Service
3.7 Date of Enter into Krabbe Disease Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Krabbe Disease Drugs Breakdown Data by Type
4.1 Global Krabbe Disease Drugs Historic Market Size by Type (2017-2022)
4.2 Global Krabbe Disease Drugs Forecasted Market Size by Type (2023-2028)
5 Krabbe Disease Drugs Breakdown Data by Application
5.1 Global Krabbe Disease Drugs Historic Market Size by Application (2017-2022)
5.2 Global Krabbe Disease Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Krabbe Disease Drugs Market Size (2017-2028)
6.2 North America Krabbe Disease Drugs Market Size by Country (2017-2022)
6.3 North America Krabbe Disease Drugs Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Krabbe Disease Drugs Market Size (2017-2028)
7.2 Europe Krabbe Disease Drugs Market Size by Country (2017-2022)
7.3 Europe Krabbe Disease Drugs Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Krabbe Disease Drugs Market Size (2017-2028)
8.2 Asia-Pacific Krabbe Disease Drugs Market Size by Country (2017-2022)
8.3 Asia-Pacific Krabbe Disease Drugs Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Krabbe Disease Drugs Market Size (2017-2028)
9.2 Latin America Krabbe Disease Drugs Market Size by Country (2017-2022)
9.3 Latin America Krabbe Disease Drugs Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Krabbe Disease Drugs Market Size (2017-2028)
10.2 Middle East & Africa Krabbe Disease Drugs Market Size by Country (2017-2022)
10.3 Middle East & Africa Krabbe Disease Drugs Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Krabbe Disease Drugs Introduction
11.1.4 GlaxoSmithKline Revenue in Krabbe Disease Drugs Business (2017-2022)
11.1.5 GlaxoSmithKline Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Krabbe Disease Drugs Introduction
11.2.4 Johnson & Johnson Revenue in Krabbe Disease Drugs Business (2017-2022)
11.2.5 Johnson & Johnson Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Krabbe Disease Drugs Introduction
11.3.4 Novartis Revenue in Krabbe Disease Drugs Business (2017-2022)
11.3.5 Novartis Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Krabbe Disease Drugs Introduction
11.4.4 Pfizer Revenue in Krabbe Disease Drugs Business (2017-2022)
11.4.5 Pfizer Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Krabbe Disease Drugs Introduction
11.5.4 Sanofi Revenue in Krabbe Disease Drugs Business (2017-2022)
11.5.5 Sanofi Recent Development
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Detail
11.6.2 Abbott Laboratories Business Overview
11.6.3 Abbott Laboratories Krabbe Disease Drugs Introduction
11.6.4 Abbott Laboratories Revenue in Krabbe Disease Drugs Business (2017-2022)
11.6.5 Abbott Laboratories Recent Development
11.7 Teva Pharmaceutical
11.7.1 Teva Pharmaceutical Company Detail
11.7.2 Teva Pharmaceutical Business Overview
11.7.3 Teva Pharmaceutical Krabbe Disease Drugs Introduction
11.7.4 Teva Pharmaceutical Revenue in Krabbe Disease Drugs Business (2017-2022)
11.7.5 Teva Pharmaceutical Recent Development
11.8 Takeda
11.8.1 Takeda Company Detail
11.8.2 Takeda Business Overview
11.8.3 Takeda Krabbe Disease Drugs Introduction
11.8.4 Takeda Revenue in Krabbe Disease Drugs Business (2017-2022)
11.8.5 Takeda Recent Development
11.9 UCB Pharmaceuticals
11.9.1 UCB Pharmaceuticals Company Detail
11.9.2 UCB Pharmaceuticals Business Overview
11.9.3 UCB Pharmaceuticals Krabbe Disease Drugs Introduction
11.9.4 UCB Pharmaceuticals Revenue in Krabbe Disease Drugs Business (2017-2022)
11.9.5 UCB Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Krabbe Disease Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Anticonvulsants
Table 3. Key Players of Muscle Relaxants
Table 4. Key Players of Others
Table 5. Global Krabbe Disease Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Krabbe Disease Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Krabbe Disease Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Krabbe Disease Drugs Market Share by Region (2017-2022)
Table 9. Global Krabbe Disease Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Krabbe Disease Drugs Market Share by Region (2023-2028)
Table 11. Krabbe Disease Drugs Market Trends
Table 12. Krabbe Disease Drugs Market Drivers
Table 13. Krabbe Disease Drugs Market Challenges
Table 14. Krabbe Disease Drugs Market Restraints
Table 15. Global Krabbe Disease Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Krabbe Disease Drugs Market Share by Players (2017-2022)
Table 17. Global Top Krabbe Disease Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Krabbe Disease Drugs as of 2021)
Table 18. Ranking of Global Top Krabbe Disease Drugs Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Krabbe Disease Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Krabbe Disease Drugs Product Solution and Service
Table 22. Date of Enter into Krabbe Disease Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Krabbe Disease Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Krabbe Disease Drugs Revenue Market Share by Type (2017-2022)
Table 26. Global Krabbe Disease Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Krabbe Disease Drugs Revenue Market Share by Type (2023-2028)
Table 28. Global Krabbe Disease Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Krabbe Disease Drugs Revenue Market Share by Application (2017-2022)
Table 30. Global Krabbe Disease Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Krabbe Disease Drugs Revenue Market Share by Application (2023-2028)
Table 32. North America Krabbe Disease Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Krabbe Disease Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Krabbe Disease Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Krabbe Disease Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Krabbe Disease Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Krabbe Disease Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Krabbe Disease Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Krabbe Disease Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Krabbe Disease Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Krabbe Disease Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 42. GlaxoSmithKline Company Detail
Table 43. GlaxoSmithKline Business Overview
Table 44. GlaxoSmithKline Krabbe Disease Drugs Product
Table 45. GlaxoSmithKline Revenue in Krabbe Disease Drugs Business (2017-2022) & (US$ Million)
Table 46. GlaxoSmithKline Recent Development
Table 47. Johnson & Johnson Company Detail
Table 48. Johnson & Johnson Business Overview
Table 49. Johnson & Johnson Krabbe Disease Drugs Product
Table 50. Johnson & Johnson Revenue in Krabbe Disease Drugs Business (2017-2022) & (US$ Million)
Table 51. Johnson & Johnson Recent Development
Table 52. Novartis Company Detail
Table 53. Novartis Business Overview
Table 54. Novartis Krabbe Disease Drugs Product
Table 55. Novartis Revenue in Krabbe Disease Drugs Business (2017-2022) & (US$ Million)
Table 56. Novartis Recent Development
Table 57. Pfizer Company Detail
Table 58. Pfizer Business Overview
Table 59. Pfizer Krabbe Disease Drugs Product
Table 60. Pfizer Revenue in Krabbe Disease Drugs Business (2017-2022) & (US$ Million)
Table 61. Pfizer Recent Development
Table 62. Sanofi Company Detail
Table 63. Sanofi Business Overview
Table 64. Sanofi Krabbe Disease Drugs Product
Table 65. Sanofi Revenue in Krabbe Disease Drugs Business (2017-2022) & (US$ Million)
Table 66. Sanofi Recent Development
Table 67. Abbott Laboratories Company Detail
Table 68. Abbott Laboratories Business Overview
Table 69. Abbott Laboratories Krabbe Disease Drugs Product
Table 70. Abbott Laboratories Revenue in Krabbe Disease Drugs Business (2017-2022) & (US$ Million)
Table 71. Abbott Laboratories Recent Development
Table 72. Teva Pharmaceutical Company Detail
Table 73. Teva Pharmaceutical Business Overview
Table 74. Teva Pharmaceutical Krabbe Disease Drugs Product
Table 75. Teva Pharmaceutical Revenue in Krabbe Disease Drugs Business (2017-2022) & (US$ Million)
Table 76. Teva Pharmaceutical Recent Development
Table 77. Takeda Company Detail
Table 78. Takeda Business Overview
Table 79. Takeda Krabbe Disease Drugs Product
Table 80. Takeda Revenue in Krabbe Disease Drugs Business (2017-2022) & (US$ Million)
Table 81. Takeda Recent Development
Table 82. UCB Pharmaceuticals Company Detail
Table 83. UCB Pharmaceuticals Business Overview
Table 84. UCB Pharmaceuticals Krabbe Disease Drugs Product
Table 85. UCB Pharmaceuticals Revenue in Krabbe Disease Drugs Business (2017-2022) & (US$ Million)
Table 86. UCB Pharmaceuticals Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Krabbe Disease Drugs Market Share by Type: 2021 VS 2028
Figure 2. Anticonvulsants Features
Figure 3. Muscle Relaxants Features
Figure 4. Others Features
Figure 5. Global Krabbe Disease Drugs Market Share by Application in 2021 & 2028
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Research Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Krabbe Disease Drugs Report Years Considered
Figure 11. Global Krabbe Disease Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Krabbe Disease Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Krabbe Disease Drugs Market Share by Region: 2021 VS 2028
Figure 14. Global Krabbe Disease Drugs Market Share by Players in 2021
Figure 15. Global Top Krabbe Disease Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Krabbe Disease Drugs as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Krabbe Disease Drugs Revenue in 2021
Figure 17. North America Krabbe Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Krabbe Disease Drugs Market Share by Country (2017-2028)
Figure 19. United States Krabbe Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Krabbe Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Krabbe Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Krabbe Disease Drugs Market Share by Country (2017-2028)
Figure 23. Germany Krabbe Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Krabbe Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Krabbe Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Krabbe Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Krabbe Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Krabbe Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Krabbe Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Krabbe Disease Drugs Market Share by Region (2017-2028)
Figure 31. China Krabbe Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Krabbe Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Krabbe Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Krabbe Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Krabbe Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Krabbe Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Krabbe Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Krabbe Disease Drugs Market Share by Country (2017-2028)
Figure 39. Mexico Krabbe Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Krabbe Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Krabbe Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Krabbe Disease Drugs Market Share by Country (2017-2028)
Figure 43. Turkey Krabbe Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Krabbe Disease Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. GlaxoSmithKline Revenue Growth Rate in Krabbe Disease Drugs Business (2017-2022)
Figure 46. Johnson & Johnson Revenue Growth Rate in Krabbe Disease Drugs Business (2017-2022)
Figure 47. Novartis Revenue Growth Rate in Krabbe Disease Drugs Business (2017-2022)
Figure 48. Pfizer Revenue Growth Rate in Krabbe Disease Drugs Business (2017-2022)
Figure 49. Sanofi Revenue Growth Rate in Krabbe Disease Drugs Business (2017-2022)
Figure 50. Abbott Laboratories Revenue Growth Rate in Krabbe Disease Drugs Business (2017-2022)
Figure 51. Teva Pharmaceutical Revenue Growth Rate in Krabbe Disease Drugs Business (2017-2022)
Figure 52. Takeda Revenue Growth Rate in Krabbe Disease Drugs Business (2017-2022)
Figure 53. UCB Pharmaceuticals Revenue Growth Rate in Krabbe Disease Drugs Business (2017-2022)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’